A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma
Shanghai Miracogen Inc.
Shanghai Miracogen Inc.
Shanghai Miracogen Inc.
Merck Sharp & Dohme LLC
Sichuan Baili Pharmaceutical Co., Ltd.
Merck Sharp & Dohme LLC
DEKA Biosciences
Shanghai JMT-Bio Inc.
MediLink Therapeutics (Suzhou) Co., Ltd.
Cyteir Therapeutics, Inc.
Merck Sharp & Dohme LLC
Genzada Pharmaceuticals USA, Inc.
Eisai Inc.
MultiVir, Inc.
Hoffmann-La Roche